开发PATH-GP (一般实践中预防和检测艾滋病毒) 干预措施:以个人为基础的方法干预开发研究,以增加艾滋病毒检测和PrEP访问
Anne Scott1,2, Hannah Family3,4, Jeremy Horwood3,4,5
1National Institute for Health and Care Research Applied Research Collaboration West at University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK anne.scott@bristol.ac.uk.
概括
通过新的干预措施,一般实践可以改善艾滋病毒检测和暴露前预防 (PrEP) 的准入. 这种多元组件方法解决了临床医生的知识和资源问题等障碍,以加强艾滋病毒预防工作.
科学领域:
- 公共卫生 公共卫生
- 一般实践 一般实践
- 预防艾滋病毒 预防艾滋病毒
背景情况:
- 艾滋病毒检测,治疗联系和暴露前预防 (PrEP) 对于早期诊断和预防至关重要.
- 一般诊所设置为增加艾滋病毒检测和PrEP可访问性提供了显著的潜力.
研究的目的:
- 开发旨在提高艾滋病毒检测率的干预措施,并在通用诊所设置中促进PrEP获取.
主要方法:
- 一个基于人的方法 (PBA) 干预开发研究在英格兰西南部进行.
- 方法包括范围审查,与医疗保健专业人员 (HCP) 和当地代表进行半结构面试,以及与医疗保健专业人员和公众的重点小组.
- 数据分析使用了PBA框架和实用定性方法.
主要成果:
- 确定的障碍包括临床医生的知识有限,资源限制和不系统的测试协议.
- 提出的解决方案包括简化测试以减少耻辱和开发多组件干预.
- 该干预包括教育,测试提示,简化测试流程,PrEP标志,患者信息和实践冠军.
结论:
- 需要进一步的研究来评估这种干预在一般实践中的可行性和有效性.
- 解决资金障碍也是成功实施和更广泛采用的关键.
相关概念视频
Primary Healthcare Services
1.9K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
1.9K
Preventive Healthcare Services
1.8K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.8K
Community Based Intervention
260
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
260
Levels of Health Promotion and Illness Prevention
14.1K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
14.1K
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K


